United States · FDA National Drug Code directory
Bupropion hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2457_ad9bfc16-be7f-4476-be28-8e7f2f4f3f73
- Product NDC
- 71335-2457
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Bupropion hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230531
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-1) · 71335-2457-1
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-2) · 71335-2457-2
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-3) · 71335-2457-3
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-4) · 71335-2457-4
- 45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-5) · 71335-2457-5
- 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-6) · 71335-2457-6
- 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-7) · 71335-2457-7
- 56 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-8) · 71335-2457-8
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-9) · 71335-2457-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →